Abstract
Background
This study was conducted to investigate the incidence of deep venous thrombosis (DVT), outcomes and its characteristics in patients with chronic heart failure (CHF) in a retrospective setting.
Outcomes
Patients died of cardiac shock or acute exacerbation of heart failure (HF), admitted to intensive care unit (ICU) due to acute exacerbation of HF, patients decided to withdraw treatment and return home due to acute exacerbation of HF.
Methods
From January 2015 to June 2022, we admitted 359 patients diagnosed with CHF, and lower limb ultrasonography was performed for the examination of DVT after admission. The incidence of DVT was recorded and patients with known risk factors of VTE were identified and excluded after incidence of DVT was calculated. Patients’ clinical data were then collected.
Results
The occurrence of DVT was 10.0% (36/359), as calf intramuscular vein thrombosis was the main constitution (n = 28, 75%). DVT patients with other factors (carcinoma, surgery, stroke, previous history of DVT) constituted a considerable part (33.3%, 12/36). Age, history of Diabetes Mellitus (DM), levels of DDi (D-Dimer), levels of alanine transferase (ALT) and left ventricular end-diastolic diameter (LVEDd) were independent predictors or risk factors of DVT in CHF patients, while chronic kidney disease (CKD) stage 1–4, white blood cell (WBC) and direct oral anticoagulant (DOAC) were protective factors. Incidence of DVT was correlated with a poor outcome of CHF patients (Pearson Chi-Square test, Value 19.612, P < 0.001).
Conclusions
In this retrospective study, incidence of DVT was found to be relatively high among hospitalized CHF patients, while patients with DVT was associated with a poor prognosis.
Similar content being viewed by others
References
Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160(22):3415–3420
Ng TMH, Tsai F, Khatri N, Barakat MN, Elkayam U (2010) Venous thromboembolism in hospitalized patients with heart failure. Circ Heart Fail 3:165–173
Alikhan R, Spyropoulos AC (2008) Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med 121:935–942
Jafri SM (1997) Hypercoagulability in heart failure. Semin Thromb Hemost 23:543–545
Piazza G, Seddighzadeh A, Goldhaber SZ (2008) Heart failure in patients with deep vein thrombosis. Am J Cardiol 101:1056–1059
Alikhan R, Cohen A, Combe S, Samama M, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson C, Turpie A (2003) Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14:341–346
Fanola CL, Norby FL, Shah AM, Chang PP, Lutsey PL, Rosamond WD, Cushman M, Folsom AR (2020) Incident heart failure and long-term risk for venous thromboembolism. J Am Coll Cardiol 75:148–158
Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ (1997) Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 29:1074–1080
Smilowitz NR, Zhao Q, Wang L, Shrestha S, Baser O, Berger JS (2019) Risk of venous thromboembolism after new onset heart failure. Sci Rep 9:17415
Melgaard L, Nielsen PB, Overvad TF, Skjøth F, Lip GYH, Larsen TB (2019) Sex differences in risk of incident venous thromboembolism in heart failure patients. Clin Res Cardiol 108:101–109
Beemath A, Stein PD, Skaf E, Al Sibae MR, Alesh I (2006) Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol 98:793–795
Ota S, Yamada N, Tsuji A, Ishikura K, Nakamura M, Ito M (2009) Incidence and clinical predictors of deep vein thrombosis in patients hospitalized with heart failure in Japan. Circ J 73:1513–1517
Darze ES, Latado AL, Guimaraes AG, Guedes RA, Santos AB, de Moura SS, Passos LC (2005) Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. Chest 128:2576–2580
Tagalakis V, Patenaude V, Kahn SR, Suissa S (2013) Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. Am J Med 126(9):832.e13–21
White R, Zhou H, Murin S, Harvey D (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:298–305
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland J, Coats A, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam C, Lyon AR, McMurray J, Mebazaa A, Mindham R, Muneretto C, Francesco PM, Price S, Rosano G, Ruschitzka F, Kathrine SA (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726
Duncan DP, Taddonio M, Chang EY, Huang BK (2019) Characterization of intramuscular calf vein thrombosis on routine knee MRI. Skeletal Radiol 48:1573–1580
Rose S, Zwiebel W, Miller F (1994) Distribution of acute lower extremity deep venous thrombosis in symptomatic and asymptomatic patients. J Ultrasound Med 13:243–250
Tebbe U, Schellong SM, Haas S, Gerlach HE, Abletshauser C, Sieder C, Bramlage P, Riess H (2011) Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study. Am Heart J 161:322–328
Cohen A, Davidson B, Gallus A, Lassen M, Prins M, Tomkowski W, Turpie A, Egberts J, Lensing A (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332:325–329
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 160:809
Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis 41:3–14
Howell MD, Geraci JM, Knowlton AA (2001) Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 54:810–816
Matsuo H, Matsumura M, Nakajima Y, Ogawa T, Tazaki J, Doi T, Yamada N, Koide T, Mo M, Suzuki T, Sarai N, Nakajima H (2014) Frequency of deep vein thrombosis among hospitalized non-surgical Japanese patients with congestive heart failure. J Cardiol 64: 430–4.
Di Nisio M, van Es N, Büller HR (2016) Deep vein thrombosis and pulmonary embolism. Lancet 388:3060–3073
Clagett G, Anderson F, Geerts W, Heit J, Knudson M, Lieberman J, Merli G, Wheeler H (1998) Prevention of venous thromboembolism. Chest 114:531S-560S
Engbers MJ, van Hylckama VA, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8:2105–2112
Zhu R, Hu Y, Tang L (2017) Reduced cardiac function and risk of venous thromboembolism in Asian countries. Thromb J 15:12
Klein L, O’Connell JB (2007) Thromboembolic risk in the patient with heart failure. Curr Treat Options Cardiovasc Med 9:310–317
Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley C, Cleland J (1994) Relationship between hemostatic abnormalities and neuroendocrine activity in heart-failure. Am Heart J 127:607–12
Jug B, Vene N, Salobir BG, Šebeštjen M, Šabovic M, Keber I (2009) Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J 50:591–600
Buckheit D, Lefemine A, Sobieraj DM, Hobbs L (2021) Venous thromboembolism prophylaxis in underweight hospitalized patients. Clin Appl Thromb Hemost 27:10760296211018752
Masotti L, Godoy DA, Napoli MD, Rabinstein AA, Paciaroni M, Ageno W (2012) Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage. Clin Appl Thromb Hemost 18:393–402
Jain H, Singh G, Kaul V, Gambhir HS (2022) Management dilemmas in restarting anticoagulation after gastrointestinal bleeding. Proc (Bayl Univ Med Cent) 35:322–327
Leonardi M, McGory M, Ko C (2006) The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis—a systematic review of 33 randomized controlled trials. Arch Surg 141:790–797
Acknowledgements
We thank our co-mentor Hong who have always inspired us to pursue knowledge of cardiology.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no potential competing interest exists.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yuan, JL., Xiao, W.K., Zhang, C.Q. et al. Incidence and characteristic of deep venous thrombosis in hospitalized chronic heart failure patients. Heart Vessels (2024). https://doi.org/10.1007/s00380-024-02377-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00380-024-02377-7